Semler Scientific, Inc.

NasdaqCM SMLR

Semler Scientific, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 34.29%

Semler Scientific, Inc. EBITDA Margin is 34.29% for the Trailing 12 Months (TTM) ending September 30, 2024, a -6.75% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Semler Scientific, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 36.77%, a 26.61% change year over year.
  • Semler Scientific, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 29.04%, a -35.01% change year over year.
  • Semler Scientific, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 44.69%, a 17.38% change year over year.
  • Semler Scientific, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 38.07%, a 16.00% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
NasdaqCM: SMLR

Semler Scientific, Inc.

CEO Dr. Douglas Murphy-Chutorian M.D.
IPO Date Feb. 21, 2014
Location United States
Headquarters 2340-2348 Walsh Avenue
Employees 92
Sector Health Care
Industries
Description

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Similar companies

INGN

Inogen, Inc.

USD 10.62

2.81%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

AORT

Artivion, Inc.

USD 29.68

1.16%

TMDX

TransMedics Group, Inc.

USD 62.54

-2.36%

TELA

TELA Bio, Inc.

USD 2.74

-1.44%

CVRX

CVRx, Inc.

USD 16.15

7.38%

LIVN

LivaNova PLC

USD 47.63

0.66%

DCTH

Delcath Systems, Inc.

USD 12.69

-0.78%

ELMD

Electromed, Inc.

USD 31.05

1.90%

APYX

Apyx Medical Corporation

USD 1.43

-4.03%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email